Hi there,
Is it possible to include this information about a questionnaire in the next HIFA forum email? Let me know if you need more information. Thank you!
[*Note from HIFA moderator: Hello Berta, please send this also to our global child health forum CHIFA: chifa@hifaforums.org ]
Questionnaire implementation of shorter regimen for non-severe TB in children
The UCL Innovative Clinical Trials Unit (formerly the MRC CTU at UCL) invites you to take part in a short, anonymous questionnaire on the uptake of a shorter treatment regimen for non-severe TB in children.
More than one million children develop TB each year, with around two thirds affected by non-severe disease. Treatment shortening is a key priority within the End TB Strategy. In 2022, the SHINE trial showed that a four-month regimen is as effective as the standard six-month regimen for children with non-severe TB, leading to updated WHO recommendations.
The questionnaire aims to:
* Assess how widely the four-month regimen has been adopted worldwide
* Understand current clinical practice across different settings
* Identify barriers to implementing the shorter regimen
The findings will help to identify gaps and inform efforts to support the integration of the four-month regimen into guidelines globally, as well as potentially inform future implementation studies.
Results will be used for research purposes, and will be reported in an anonymised, aggregated form, and may be used for scientific publications.
You can access the questionnaire below:
https://forms.office.com/e/WMuWkzCuMx?origin=lprLink
The questionnaire should take about ten minutes to complete.
Please share this invitation with colleagues who look after children with TB.
Thank you very much for your time and support.
Dr Berta Terre-Torras (she/her)
Science Communications Officer
UCL Innovative Clinical Trials Unit
Institute of Clinical Trials & Methodology
90 High Holborn, London WC1V 6LJ
For more information visit the Innovative Clinical Trials Unit website<http://www.innovative-ctu.ucl.ac.uk/> and follow our social media accounts: LinkedIn<https://www.linkedin.com/company/innovative-ctu/>, BlueSky<https://bsky.app/profile/innovative-ctu.bsky.social> and YouTube<https://www.youtube.com/@innovative-ctu>. To listen to our latest podcast episodes go to our SoundCloud page.<https://soundcloud.com/trial-talk-podcast>
The MRC Clinical Trials Unit at UCL became the UCL Innovative Clinical Trials Unit in April 2026<https://www.innovative-ctu.ucl.ac.uk/news/news-stories/2026/february/mrc.... The Innovative Clinical Trials Unit is continuing the mission of smarter studies and global impact, leading to better health.
Please note that my working days are Monday to Thursday.
HIFA profile: Berta Terre Torras is Science Communications Officer at UCL Innovative Clinical Trials Unit, United Kingdom. Professional interests: Clinical Trials, HIV, patient involvement, community engagement. Email address: b.torras AT ucl.ac.uk